Clinical Trials Directory

Trials / Terminated

TerminatedNCT03026192

Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure

Use of Near Infrared Spectroscopy in Preterm Infants to Determine Patent Ductus Arteriosus Closure Following Medical Treatment

Status
Terminated
Phase
Study type
Observational
Enrollment
4 (actual)
Sponsor
Albany Medical College · Academic / Other
Sex
All
Age
1 Minute – 1 Week
Healthy volunteers
Accepted

Summary

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.

Conditions

Interventions

TypeNameDescription
DEVICEnear infrared spectroscopyNear infrared spectroscopy will be placed on infants both with and without hsPDA

Timeline

Start date
2016-12-01
Primary completion
2018-06-30
Completion
2018-06-30
First posted
2017-01-20
Last updated
2019-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03026192. Inclusion in this directory is not an endorsement.

Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure (NCT03026192) · Clinical Trials Directory